2022
Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
Tindana P, Guissou R, Bolarinwa O, Tou F, de Haan F, Dhorda M, Dondorp A, Amaratunga C, Mokuolu O, Ouedraogo J, Cheah P. Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria. PLOS ONE 2022, 17: e0273249. PMID: 36083995, PMCID: PMC9462557, DOI: 10.1371/journal.pone.0273249.Peer-Reviewed Original ResearchConceptsTriple artemisinin-based combination therapiesArtemisinin-based combination therapyCombination therapyArtemisinin resistanceUncomplicated Plasmodium falciparum malariaDrug resistancePlasmodium falciparum malariaMalaria-endemic countriesPartner drug resistanceAdditional side effectsUncomplicated malariaFalciparum malariaTreatment optionsEndemic countriesPediatric diseasesSide effectsACT failureMalariaTherapyBurkina FasoFocus group discussionsEthical considerationsTreatmentQualitative studyStakeholder engagement activities
2016
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
Ménard D, Khim N, Beghain J, Adegnika A, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos M, Cao J, Chen J, Collet L, Cui L, Thakur G, Dieye A, Djallé D, Dorkenoo M, Eboumbou-Moukoko C, Espino F, Fandeur T, Ferreira-da-Cruz M, Fola A, Fuehrer H, Hassan A, Herrera S, Hongvanthong B, Houzé S, Ibrahim M, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner P, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati J, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo J, Pillai D, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué K, Sirima S, Sutherland C, Syafruddin D, Tahar R, Tang L, Touré O, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale J, Stokes B, Straimer J, Witkowski B, Fidock D, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O. A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. New England Journal Of Medicine 2016, 374: 2453-2464. PMID: 27332904, PMCID: PMC4955562, DOI: 10.1056/nejmoa1513137.Peer-Reviewed Original ResearchConceptsK13 mutationsRing-stage survival assayK13-propeller polymorphismsPlasmodium falciparum resistanceA578S mutationParasite clearanceRare nonsynonymous mutationsFalciparum resistanceAntimalarial resistanceArtemisinin resistanceNationwide surveillanceGlobal burdenSentinel sitesGeographic disparitiesSurvival assaysP. falciparum genesMalariaPropeller domainMajor determinantArtemisininMutationsNonsynonymous mutationsSuch resistancePolymorphismPatientsGenomic epidemiology of artemisinin resistant malaria
Amato R, Miotto O, Woodrow C, Almagro-Garcia J, Sinha I, Campino S, Mead D, Drury E, Kekre M, Sanders M, Amambua-Ngwa A, Amaratunga C, Amenga-Etego L, Andrianaranjaka V, Apinjoh T, Ashley E, Auburn S, Awandare G, Baraka V, Barry A, Boni M, Borrmann S, Bousema T, Branch O, Bull P, Chotivanich K, Conway D, Craig A, Day N, Djimdé A, Dolecek C, Dondorp A, Drakeley C, Duffy P, Echeverry D, Egwang T, Fairhurst R, Faiz A, Fanello C, Hien T, Hodgson A, Imwong M, Ishengoma D, Lim P, Lon C, Marfurt J, Marsh K, Mayxay M, Michon P, Mobegi V, Mokuolu O, Montgomery J, Mueller I, Kyaw M, Newton P, Nosten F, Noviyanti R, Nzila A, Ocholla H, Oduro A, Onyamboko M, Ouedraogo J, Phyo A, Plowe C, Price R, Pukrittayakamee S, Randrianarivelojosia M, Ringwald P, Ruiz L, Saunders D, Shayo A, Siba P, Takala-Harrison S, Thanh T, Thathy V, Verra F, Wendler J, White N, Ye H, Cornelius V, Giacomantonio R, Muddyman D, Henrichs C, Malangone C, Jyothi D, Pearson R, Rayner J, McVean G, Rockett K, Miles A, Vauterin P, Jeffery B, Manske M, Stalker J, MacInnis B, Kwiatkowski D. Genomic epidemiology of artemisinin resistant malaria. ELife 2016, 5: e08714. PMID: 26943619, PMCID: PMC4786412, DOI: 10.7554/elife.08714.Peer-Reviewed Original ResearchConceptsKelch13 mutationsArtemisinin-resistant Plasmodium falciparumArtemisinin-resistant malariaResistant Plasmodium falciparumGenomic epidemiologyLarge global surveyPublic health surveillanceArtemisinin resistanceResistant malariaCurrent epidemicHealth surveillancePlasmodium falciparumAmino acid changesEpidemiologyKelch13Non-synonymous mutations
2013
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Miotto O, Almagro-Garcia J, Manske M, MacInnis B, Campino S, Rockett K, Amaratunga C, Lim P, Suon S, Sreng S, Anderson J, Duong S, Nguon C, Chuor C, Saunders D, Se Y, Lon C, Fukuda M, Amenga-Etego L, Hodgson A, Asoala V, Imwong M, Takala-Harrison S, Nosten F, Su X, Ringwald P, Ariey F, Dolecek C, Hien T, Boni M, Thai C, Amambua-Ngwa A, Conway D, Djimdé A, Doumbo O, Zongo I, Ouedraogo J, Alcock D, Drury E, Auburn S, Koch O, Sanders M, Hubbart C, Maslen G, Ruano-Rubio V, Jyothi D, Miles A, O'Brien J, Gamble C, Oyola S, Rayner J, Newbold C, Berriman M, Spencer C, McVean G, Day N, White N, Bethell D, Dondorp A, Plowe C, Fairhurst R, Kwiatkowski D. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nature Genetics 2013, 45: 648-655. PMID: 23624527, PMCID: PMC3807790, DOI: 10.1038/ng.2624.Peer-Reviewed Original ResearchConceptsArtemisinin-resistant Plasmodium falciparumPlasmodium falciparum samplesArtemisinin resistancePlasmodium falciparumDistinct subpopulations